Veradermics (MANE) Current Assets (2024 - 2026)

Veradermics (MANE) has 3 years of Current Assets data on file, last reported at $397.1 million in Q1 2026.

• Quarterly Current Assets changed N/A year-over-year to $397.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.1 million (changed N/A YoY) and the FY2025 annual result came in at $152.5 million, up 174.59% from the prior year.
• Current Assets rose to $397.1 million in Q1 2026, from $152.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $397.1 million in Q1 2026 to a low of $55.5 million in Q4 2024.
• A 3-year average of $201.7 million and a median of $152.5 million in 2025 frame the typical range for Current Assets.
• The widest YoY moves for Current Assets: up 174.59% in 2025, down 174.59% in 2025.
• Tracing MANE's Current Assets over 3 years: stood at $55.5 million in 2024, then soared by 174.59% to $152.5 million in 2025, then soared by 160.38% to $397.1 million in 2026.
• The last three Current Assets figures came in at $397.1 million (Q1 2026), $152.5 million (Q4 2025), and $55.5 million (Q4 2024), per Business Quant data.